Factors impacting severe disease from chikungunya infection: Prioritizing chikungunya vaccine when available

Affiliations

¹ Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Location Amsterdam, Amsterdam Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands; Institut für Tropenmedizin, German Center for Infection Research (DZIF), Tübingen University, Tübingen, Germany; Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Masanga Medical Research Unit, Masanga, Sierra Leone. Electronic address: m.p.grobusch@amsterdamumc.nl.
² Weill Cornell Medicine, New York, NY, USA; The New York Center for Travel and Tropical Medicine, New York, NY, USA.

Editorial

Martin P Grobusch et al. Travel Med Infect Dis. 2022 Sep-Oct.

. 2022 Sep-Oct:49:102391.

doi: 10.1016/j.tmaid.2022.102391. Epub 2022 Jun 22.

¹ Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Location Amsterdam, Amsterdam Infection & Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands; Institut für Tropenmedizin, German Center for Infection Research (DZIF), Tübingen University, Tübingen, Germany; Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Masanga Medical Research Unit, Masanga, Sierra Leone. Electronic address: m.p.grobusch@amsterdamumc.nl.
² Weill Cornell Medicine, New York, NY, USA; The New York Center for Travel and Tropical Medicine, New York, NY, USA.

No abstract available

Keywords: Arthritis; Chikungunya; Long-term sequelae; Severe disease; Vaccine.

Conflict of interest statement

Declaration of competing interest Both authors declare no conflict of interest.